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NF-protocadherin (NFPC)-mediated cell– cell adhesion plays a critical role in vertebrate neural tube formation. NFPC is also expressed
during the period of axon tract formation, but little is knownabout its function in axonogenesis. Herewehave tested the role ofNFPCand
its cytosolic cofactor template-activating factor 1 (TAF1) in the emergence of the Xenopus retinotectal projection. NFPC is expressed in
the developing retina and optic pathway and is abundant in growing retinal axons. Inhibition of NFPC function in developing retinal
ganglion cells (RGCs) severely reduces axon initiation and elongation and suppresses dendrite genesis. Furthermore, an identical phe-
notype occurs when TAF1 function is blocked. These data provide evidence that NFPC regulates axon initiation and elongation and
indicate a conserved role for TAF1, a transcriptional regulator, as a downstream cytosolic effector of NFPC in RGCs.
Key words: retinal growth cone; NFPC; TAF1; axon; protocadherin; cell adhesion molecule
Introduction
Nervous system development requires the coordinated regula-
tion of cellular interactions, which are mediated through cell ad-
hesion molecules, including the cadherins. The classical cad-
herins have been implicated in multiple aspects of neural
development, including neurite outgrowth, axon pathfinding,
and synaptogenesis (Hirano et al., 2003). More recently, new
subgroups of the cadherin superfamily have been identified, in-
cluding desmosomal, Fat, and seven-pass transmembrane (7-
TM) cadherins. These proteins differ from the classical cadherins
in that they possess varying numbers of extracellular cadherin
(EC) repeats and have divergent cytoplasmic domains. Many of
thesemolecules are critical for neural development. For instance,
photoreceptor target selection in Drosophila requires the 7-TM
cadherin Flamingo, (Lee et al., 2003) and Celsr3, a mammalian
Flamingo ortholog, regulates the formation of axon tracts, in-
cluding the anterior commissure (Tissir et al., 2005).
The protocadherins comprise another phylogenetically dis-
tinct group of the cadherin superfamily and are often expressed
within spatially restricted domains in the central nervous system
(Hirano et al., 2003). For instance, protocadherin 7 (pcdh7) is
expressed in the Purkinje cells and vomeronasal organ of the
developing mouse brain (Redies et al., 2005) and in the cerebral
cortex of the adult (Yoshida et al., 1999). One function that pro-
tocadherins may regulate during neural development is axono-
genesis, as a recent report has described aberrant axon tract for-
mation in the ventral telencephalon of OL-protocadherin-
deficient mice (Uemura et al., 2007). However, the mechanisms
underlying protocadherin-mediated axonal extension, in partic-
ular the identity of cytosolic cofactors for neuronal protocad-
herins, remain poorly defined.
NF-protocadherin (NFPC), the Xenopus homolog of pcdh7,
regulates ectodermal cell sorting (Bradley et al., 1998) and neural
tube closure (Rashid et al., 2006) during embryogenesis. We
demonstrate that NFPC is highly expressed in the developing
retina and is particularly abundant in retinal ganglion cell (RGC)
axons and growth cones. Dominant inhibition of NFPC function
in single neurons in vivo elicited defects in RGC axon and den-
drite initiation and elongation. In addition, template-activating
factor 1 (TAF1) is also highly expressed in RGCs, consistent with
its known role as a cytosolic cofactor for NFPC (Heggem and
Bradley, 2003). Furthermore, a dominant-negative TAF1 protein
produced a phenotype that mimicked NFPC inhibition, indicat-
ing that RGC axon and dendrite outgrowth in vivo requires
TAF1-mediated NFPC function.
Materials andMethods
Retinal cultures. Xenopus laevis embryos, obtained by in vitro fertilization,
were raised in 0.1 modified Barth’s saline (14–20°C). Retinal explant
culture was performed as described previously (Piper et al., 2006).
In situ hybridization. Whole-mount (see Fig. 1B,C) and section (see
Fig. 1A,G) in situ hybridization was performed using NFPC- and TAF1-
specific probes (Rashid et al., 2006). Sense probes displayed no specific
staining. Horseradish peroxidase (HRP) labeling of RGC axons was per-
formed as described previously (Piper et al., 2006).
Immunofluorescent labeling. Polyclonal antibodies against TAF1 (Ac-
tive Motif, Carlsbad, CA) or the cytoplasmic domain of NFPC, followed
by incubation with a fluorescent secondary (goat anti-rabbit IgG Alex-
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aFluor594, Invitrogen, Carlsbad, CA) were used to detect these proteins
using standard protocols. To visualize cells expressing myc-tagged
dominant-negative constructs, an anti-myc antibody (9E10, Sigma, St.
Louis, MO) was used, followed by incubation with a fluorescent second-
ary antibody (goat anti-mouse IgG AlexaFluor594, Invitrogen).
Plasmids. Membrane-targeted GFP (GAP-GFP), cloned into pCS2
vector (Das et al., 2003), was used as the negative control. To inhibit
NFPC, a deletion construct, NFE, lacking the 836 aa comprising the
extracellular (EC) region was used (Bradley et al., 1998). The NFN
construct lacks both the EC domain and the cytoplasmic juxtamembrane
71 aa of NFPC (Heggem and Bradley, 2003). To inhibit TAF1, a deletion
construct, TAF1N, lacking the first 141 aa of this protein was used
(Rashid et al., 2006). Each construct was cloned into pCS2 and was
myc-tagged at theN terminus (TAF1N) orC terminus (NFE,NFN).
In vivo lipofections. For each deletion construct, colipofections were
performedwithGAP-GFP to enable selection of lipofection-positive em-
bryos. DNAwasmixed with DOTAP (Roche, Indianapolis, IN) at a ratio
of 1 g:3 l before injection into the proliferating retinal neuroepithe-
lium of stage 19 embryos. The first retinal neurons are born at stage
25/26, when expression of exogenous constructs begins (Holt et al.,
1990). At stage 40, whenRGC axons first enter the optic tectum, embryos
were fixed (4% paraformaldehyde) and mounted in OCT (TissueTEK),
and 30 m serial cryosections cut in the transverse plane. Retinal cells
expressing the dominant-negative constructs were detected using immu-
nofluorescent detection of the myc epitope.
Analysis. The retinotectal pathway was imaged at 20 magnification
using a Nikon Optiphot inverted microscope and a Hamamatsu digital
CCD camera. Neurons were scored as RGCs if their somata were located
in the ganglion cell layer of the retina. Axon and primary dendrite length
of myc-positive (dominant-negative constructs) or GAP-GFP-positive
(control) RGCs were traced andmeasured using
Openlab (Improvision, Lexington, MA). Data
represent pooled results from at least three inde-
pendent experiments.
Statistics. Statistical analyses were performed
using ANOVA (Kruskal–Wallis with posttest) or
 2 tests. Error bars represent SEM.
Results
NFPC is expressed in RGCs and along
the retinotectal pathway
NFPC is expressed in the developing eye
(Bradley et al., 1998), but its pattern of ex-
pression in specific retinal cell types and its
distribution within the entire optic path-
way is uncharacterized. To address this we
performed in situ hybridization (ISH) with
an NFPC-specific probe. ISH on transverse
sections of the eye show NFPC expression
in the differentiating central portion of the
retina at stage 40, including the RGC and
inner nuclear cell layers, and is particularly
high in the inner plexiform layer (IPL) and
the optic nerve head (ONH), where the
dendrites and axons of RGCs reside, re-
spectively (Fig. 1A). This suggests that
NFPC message is trafficked into RGC den-
drites and axons. Whole-mount ISH on
stage 40 Xenopus brains demonstrated that
NFPC mRNA is also expressed in the optic
tract and optic tectum (Fig. 1B).Moreover,
anterograde HRP labeling of retinal axons
in these brains verified that NFPC mRNA
colocalizes with RGC axons in the optic
tract (Fig. 1C). To determine whether the
ISH labeling in the optic tract region re-
flected transcripts localized exclusively to
retinal axons and/or the underlying neuroepithelial substrate,
embryonic eyes were removed before RGC axonogenesis (stage
26). ISH performed on the brains from these eyeless embryos at
stage 40 showed persistent, although slightly reduced, expression
of NFPC in the optic pathway (data not shown), suggesting that
NFPC is expressed in the neuroepithelial substrate in addition to
the RGC axons.
To examine protein distribution in the retina, immunocyto-
chemistry was performed on sectionedmaterial. NFPC immuno-
labeling closelymatched the pattern of ISH staining (Fig. 1D). To
test whether NFPC protein is expressed in the growth cones of
retinal axons, immunocytochemistry was performed on retinal
explants cultured from embryos of ages varying from stage 24 to
stage 42 (Fig. 1E; data not shown). Growth cones showed strong
punctate staining, indicating that NFPC protein is present in
RGC growth cones during the period of retinal axonogenesis.
Dominant-negative NFPC inhibits development of
RGC processes
To determine the role of NFPC in RGC development, we sought
to block its function in vivo by expressing a dominant-negative
form of NFPC. We used a construct lacking the EC domain of
NFPC (NFE), which was shown previously to inhibit endoge-
nous function (Bradley et al., 1998). Lipofection of this myc-
tagged NFPC mutant into eye primordia at stage 19 gave rise to
multiple myc-positive neurons in the retina at stage 40. We
first assessed whether expression of the mutant protein altered
Figure 1. Retinal expression of NFPC and TAF1. A, Transverse section of a stage 40 retina, showing NFPCmRNA expression in
the plexiform layers (arrowheads), ONH (double arrowhead), and RGC layer (arrow).B,Whole-mount ISH of an isolated stage 40
brain. NFPC mRNA delineates the optic tract (arrowhead) and is seen in the forebrain (arrow), tectum (double arrowhead), and
hypothalamus (open arrowhead). A, Anterior; D, dorsal; P, posterior; V, ventral. C, Reverse side of the brain shown inB, in which
retinal axons have been HRP filled, so they appear brown. The HRP signal is coincident with NFPC mRNA in the optic tract. D, At
stage 40, the lens, plexiform layers (arrowheads), RGCs (arrow), and ONH (double arrowhead) express NFPC protein. E, Cultured
RGC neurite from a stage 24 retinal explant expressing NFPC on the neurite shaft and growth cone. F, Retinal TAF1 mRNA
expression is found in the RGC layer (arrow), ONH (double arrowhead), and the plexiform layers (arrowheads) at stage 40. G,
Cultured stage 24 retinal neurite expressing TAF1. IF, Immunofluorescence. Dotted lines in E and G delineate the edge of the
growth cone. Scale bar: B, C, 400m; A, D, F, 250m; E, G, 5m.
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retinal patterning. Both neuronal differentiation and laminar
migration appeared normal in NFE-expressing cells, as ex-
amples of all retinal cell types expressing the dominant-
negative protein were observed and were located in their cor-
rect laminar position (Fig. 2). Staining with the nuclear
marker DAPI demonstrated no evidence of increased apopto-
sis, characterized by pyknotic nuclei, suggesting that NFE-
expressing cells are viable at this stage. Similar results were
observed with the NFN (lacks both EC and cytoplasmic jux-
tamembrane domains; see Materials and Methods) and
TAF1N constructs (data not shown; see Materials and Meth-
ods). In summary, inhibition of NFPC function does not ap-
pear to affect laminar migration or fate determination.
However, closer examination indicated that axon and den-
drite extension were impaired in NFE-expressing RGCs (Fig.
2F–H). NFE-expressing RGCs often possessed dendrites but
lacked an axon (Fig. 2F), exhibited only a short axon (Fig. 2G) or,
in some cases, possessed no processes at all (Fig. 2H), a pheno-
type rarely observed in controls. In contrast, RGCs expressing
GAP-GFP alone exhibited normal phenotypeswithmultiple den-
drites and an axon that exited the eye via the ONH (Fig. 2 I). One
possible explanation for the apparent lack of axons/dendrites is
that the myc-tagged truncated NFPC protein used for immuno-
detection is not trafficked efficiently into axons and dendrites.
Thus, processes might be present but escape detection with myc
immunocytochemistry. To address this, we colipofected the
dominant-negative constructswithGAP-GFP. TheGAP-GFP fu-
sion protein is targeted to themembrane by theGAP-tag and so is
detectable throughout the soma and the processes of transfected
cells (Das et al., 2003). As can be seen in Figure 2F–H, expression
of NFE and GAP-GFP in colipofected RGCs was almost identi-
cal, suggesting that the mutant protein is distributed to the distal
processes of the RGC as efficiently as the GFP marker, validating
our analysis of RGC processes through immunodetection of the
mutant protein alone.
We next quantified the presence and length of both axons and
dendrites in RGCs expressing NFE or GAP-GFP controls by
tracing lengths of these processes in serial sections (Fig. 3). Axon
initiation was strongly inhibited in NFE-expressing RGCs, with
34.2% of RGCs expressing this protein failing to extend an axon,
a phenotype only observed in 6.1% of GAP-GFP controls. Of
those RGCs expressing NFE that did extend an axon, growth
through the optic pathwaywas severely retarded,with only 17.1%
reaching the tectum by stage 40, as opposed to 69.7% in the
control. Indeed, the average length of NFE-expressing axons
was significantly shorter (305.4  42 m) than GAP-GFP-
expressing axons (681.0 28 m). We also analyzed embryos at
stage 43 to determine whether this phenotype was attributable to
an overall delay in RGC maturation. The axon length of stage 43
RGCs expressing the NFE construct was not significantly in-
creased compared with those at stage 40 (data not shown), sug-
gesting that the impairment of axon extension is not caused by
delayed RGC development.
The effect of NFE expression on RGC dendritogenesis was
less severe than on axonogenesis. Although the percentage of
NFE-expressing RGCs with dendrites versus the control was
Figure2. NFE-expressing cells differentiate intomultiple retinal cell types.A–H, Transverse sections of stage40 retinas immunolabeledwith ananti-myc antibody to identifyNFE-expressing
cells. NFE-expressing cells can differentiate into photoreceptors (A, ph), horizontal cells (B, ho), Mu¨ller glia (C, mg), bipolar cells (D, bi), amacrine cells (E, am), and RGCs (F–H ). Some RGCs
expressing NFE possess only dendrites (F, arrowheads) or only an axon (G, arrow), whereas some lack all processes (H ). Embryos were cotransfected with GAP-GFP, and the distribution of NFE
(F–H ) and GAP-GFP (F–H) in RGCswas very similar, illustrating NFE is transported through the axodendritic field. I, RGC transfectedwith GAP-GFP alone, withmultiple dendrites (arrowheads)
and an axon extending to the ONH (arrow). PE, Pigment epithelium. Scale bar, 25m.
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very similar (94.7% vs 93.9%), those cells expressing NFE ex-
hibited significantly fewer dendrites (2.03 0.11) than the con-
trol (2.91 0.14) and, moreover, the average length of dendrites
in cells expressing NFE (10.90  0.43 m) was significantly
shorter than the control (13.65 0.42 m). These data demon-
strate that NFPC function is required for axon and dendrite ini-
tiation and elongation in vivo.
Dominant-negative blockade of TAF1 phenocopies
NFPC inhibition
The cytoplasmic juxtamembrane region of NFPC interacts with
TAF1, and TAF1 is required for NFPC-mediated cell adhesion in
the embryonic ectoderm (Heggem and Bradley, 2003). There-
fore, we extended our analysis to investigate the pattern of TAF1
expression in the optic pathway and found that it is highly en-
riched in the IPL and ONH of the developing retina (Fig. 1F).
Furthermore, immunocytochemistry on cultured retinal ex-
plants showed that TAF1 protein is also expressed in retinal
growth cones (Fig. 1G). Importantly, the data indicate that both
NFPC and TAF1 are expressed in RGCs, prompting us to assess
the functional role of TAF1 in their development. We used a
deletion construct, TAF1N, previously shown to inhibit TAF1
function in vivo (Rashid et al., 2006). The results observed were
similar to that obtained with NFE. Axon initiation from
TAF1N-expressing RGCs was severely impaired, with only
67.3% possessing an axon (Fig. 3). Of these, only a small percent-
age had reached the tectum by stage 40 (6.1%), with the average
axon length (267.3 41m) being significantly shorter than the
GAP-GFP controls. Similarly, although most of the RGCs ex-
pressing the mutant protein possessed dendrites, the average
number of dendrites per RGC (2.02  0.13) was reduced com-
pared with the control, as was the average dendrite length
(10.10 0.55 m). This phenocopy of NFPC perturbation sug-
gests that TAF1 could play an important role by acting down-
stream of NFPC during the development of RGC processes in
vivo.
The cytoplasmic juxtamembrane region of NFE is essential
for inhibition of NFPC
NFE is thought to function by competing with endogenous
NFPC for binding to cytosolic cofactors. Because previous re-
search demonstrated that TAF1 binds to the juxtamembrane re-
gion of NFPC’s cytoplasmic domain (Heggem and Bradley,
2003), we sought to verify that this region is important for the
dominant-negative effect of NFE in developing RGCs. To ad-
dress this, we transfected RGCs with a NFPC construct lacking
both the EC and cytoplasmic juxtamembrane domains (NFN).
This construct, when expressed in the embryonic ectoderm, does
not disrupt NFPC function, because it is unable to compete for
the binding of endogenous TAF1 (Heggem and Bradley, 2003).
As shown in Figure 3, analysis of RGCs expressingNFN showed
that neither axon nor dendrite initiation differed significantly
from the GAP-GFP control, nor did the proportion of NFN-
expressing axons reaching the tectum. Furthermore, the length of
NFN-expressing axons (581.4  29 m) and dendrites
(13.87 0.38 m) was comparable with those expressing GAP-
GFP. These data demonstrate that the cytoplasmic juxtamem-
brane domain is essential for the dominant-negative effect of
NFE and, collectively, these data point to TAF1 as the cytoplas-
mic binding partner important for axonal and dendritic behavior
regulated by NFPC.
Inhibition of axon growth throughout the optic pathway
The localized expression of NFPC within retinal axons and along
the optic pathway is indicative of a role during RGC axon elon-
gation. To clearly visualize where dominantly inhibited axons
were located within the optic pathway, we next did a distribution
analysis of axon lengths from each sample group by placing them
into 100 m intervals and plotted the resulting spread of data
onto a histogram. From this, it is clear that axons from RGCs
expressing either GAP-GFP or NFN were most frequently
found in the distal optic tract and tectum, with the majority hav-
ing lengths500m (Fig. 4). In contrast, most RGCs expressing
NFE or TAF1N have either no axons or shorter axons (100–
200m), with the subsequent intervals generally having decreas-
ing representation. Because we did not observe a specific point
within the retinotectal pathway in which axons from NFE- or
TAF1N-expressing RGCs were accumulating, we infer that in-
hibition of NFPC or TAF1 causes a general impairment of retinal
axon growth during development.
Discussion
Our results show thatNFPCandTAF1 are expressed inRGCs and
that inhibition of either NFPC or TAF1 function in vivo severely
impairs axon and dendrite extension. These findings, together
with recent reports showing that -protocadherins regulate syn-
aptic development in spinal cord neurons (Weiner et al., 2005),
Figure3. NFE and TAF1N impair axon anddendrite initiation andoutgrowth fromRGCs.
Quantitative analysis of GAP-GFP-, NFE-, NFN-, and TAF1N-expressing RGCs at stage 40.
A, The percentage of RGCs with axons was significantly reduced in cells expressing NFE or
TAF1N compared with RGCs expressing GAP-GFP. B, C, Althoughmany axons from GAP-GFP-
or NFN-expressing RGCs reached the tectum, the percentage of axons reaching the tectum
was significantly smaller in NFE- or TAF1N-expressing cells (B), and these RGCs had on
average significantly shorter axons (C). D–F, The number of RGCs with dendrites was similar
between all sample groups (D), but RGCs expressing NFE or TAF1N had significantly fewer
(E) and shorter (F ) dendrites per cell. Numbers in bars indicate RGCs analyzed for each group.
*p 0.0005, 2 test; **p 0.001, Kruskal–Wallis test.
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and OL-protocadherin controls striatal axon elongation in the
ventral telencephalon (Uemura et al., 2007), implicate protocad-
herins as general players in axonogenesis and dendritogenesis.
Although it is apparent that NFPC plays an integral role in
RGC axon and dendrite elongation, its precise function at the
level of the growth cone is unclear. NFPC was first identified as a
regulator of embryonic ectodermal formation inXenopus. In vivo
inhibition of NFPCwithNFE resulted in a failure of the nascent
ectodermal layers to juxtapose, indicating a failure of adhesion in
those NFE-expressing regions (Bradley et al., 1998). NFPC has
also been implicated in the regulation of neural tube closure
(Rashid et al., 2006). Interestingly, ectodermal overexpression of
NFPC induced cell sorting, with NFPC-expressing cells cluster-
ing together, a phenotype indicative of NFPC acting as a ho-
mophilic adhesion molecule (Bradley et al., 1998). Homophilic
binding has also been reported for other protocadherins (Hirano
et al., 2003). The expression of NFPC on RGC axons and along
the optic pathway neuroepithelium (Fig. 1) is certainly consistent
with a role for homophilic NFPC binding regulating axon exten-
sion through the retinotectal pathway. Similarly, homophilic
binding betweenNFPC expressed onRGCdendrites and the pro-
cesses of other retinal neurons may facilitate dendrite extension.
Alternatively, NFPC may regulate the activity of other cell
adhesion molecules. Evidence supporting this hypothesis has
come from an investigation of Xenopus paraxial protocadherin
(PAPC). Blastomere adhesion assays and in vitro cell culture ex-
periments indicate that PAPC, instead of mediating adhesion via
homophilic binding, may function to downregulate the activity
of C-cadherin (Chen and Gumbiner, 2006). NFPC could func-
tion in an analogousmanner during optic pathway development,
because RGCs also express N-cadherin, and, moreover, blockade
of N-cadherin function causes axonal and dendritic defects sim-
ilar to that caused by NFPC inhibition (Riehl et al., 1996). Our
data are also consistent with this hypothesis. Further experimen-
tation will be required to ascertain whether NFPC acts as a ho-
mophilic adhesion molecule during RGC axon and dendrite de-
velopment or whether it functions to regulate N-cadherin within
the growth cone.
Our data also demonstrates a novel role for TAF1 in the reg-
ulation of axon and dendrite elongation in vivo. Interestingly,
TAF1 regulates histone acetylation and transcription as part of
the INHAT (inhibitor of acetyltransferase) complex (Seo et al.,
2001). As well as being localized to the nucleus, TAF1 is found in
the cytosol and interacts with the cytoplasmic juxtamembrane
region of NFPC in vitro and in vivo (Heggem and Bradley, 2003).
Although we have not demonstrated a direct interaction between
these molecules in RGCs, coexpression of NFPC and TAF1, as
well as the very similar defects observed when either molecule is
inhibited, strongly suggest that they interact during retinal devel-
opment. Furthermore, the importance of the TAF1-binding do-
main of NFPC in mediating the function of this protocadherin is
demonstrated by the fact thatNFNdoes not inhibitNFPC func-
tion in ectodermal adhesion assays (Heggem and Bradley, 2003)
or RGC process extension (this study). What remains to be de-
fined are the events occurring downstream of TAF1 binding.
TAF1 may play a role in downstream signaling from NFPC, be-
cause it has been shown to bind p35nck5a, the activator of cyclin-
dependent kinase 5 (Cdk5), and to enhance Cdk5/p35nck5a activ-
ity (Qu et al., 2002). Cdk5 is abundant in postmitotic neurons
and is localized to extending axons of chick RGCs, where it reg-
ulates growth cone elongation and stabilization (Hahn et al.,
2005). Protein phosphatase 2A (PP2A), which regulates phos-
phorylation of key signaling pathways including the MEK/ERK
cascade in neurons (Mao et al., 2005), is another candidate for
signaling downstreamofNFPC/TAF1, because TAF1 can interact
with and regulate the activity of this enzyme (Li et al., 1996).
Aside from extension, the disruption of axon and dendrite
initiation reflects a defect in early RGC development. How could
NFPC and TAF1 regulate this process? Consistent with a role in
early RGC development, TAF1 could itself be translocated to the
nucleus to regulate programs of gene expression leading to pro-
cess initiation. A second possibility is that downstream signaling
from TAF1 within the cytosol may regulate axonal and dendritic
specification, perhaps through Cdk5 (Qu et al., 2002). The Akt
signaling pathway, a key node within the process of neuronal
polarization (Yoshimura et al., 2006), is regulated by Cdk5 in rat
cortical neurons (Li et al., 2003), and Rac1, another integral com-
ponent for axon specification, functions with Cdk5 to control
axon initiation (Ruchhoeft et al., 1999). PP2A may also be rele-
vant for this process, because it modulates the activity of the Par
complex [Par3/Par6/atypical protein kinase C (aPKC)], an im-
portant determinant for neuronal polarization and axon specifi-
cation. PP2A regulates the activity and distribution of aPKC
(Nunbhakdi-Craig et al., 2002) and is required for the localiza-
tion of Bazooka, a component of the Par6 complex, inDrosophila
photoreceptors (Nam et al., 2007). Although the mechanism is
currently unclear, our data clearly point to TAF1 as an important
mediator of NFPC function during the initial stages of RGC pro-
cess specification. In conclusion, our results demonstrate that
TAF1-mediated NFPC function is required in vivo for axon and
dendrite initiation and elongation fromRGCs, providing the first
indication that this molecular couplet regulates these critical
functions during nervous system development.
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